Daniel Bradbury - Jan 3, 2023 Form 4 Insider Report for CASTLE BIOSCIENCES INC (CSTL)

Role
Director
Signature
/s/ Greg Acosta, Attorney-in-fact
Stock symbol
CSTL
Transactions as of
Jan 3, 2023
Transactions value $
-$176,316
Form type
4
Date filed
1/5/2023, 04:25 PM
Previous filing
Dec 5, 2022
Next filing
Feb 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CSTL Common Stock Sale -$160K -7K -3.38% $22.82 200K Jan 3, 2023 By LLC F1, F2, F3
transaction CSTL Common Stock Sale -$16.5K -700 -0.35% $23.55 200K Jan 3, 2023 By LLC F1, F3, F4
holding CSTL Common Stock 830 Jan 3, 2023 Direct
holding CSTL Common Stock 97.8K Jan 3, 2023 By Daniel Bradbury Irrecovable Descendant's Trust F5
holding CSTL Common Stock 97.8K Jan 3, 2023 By Annette Bradbury Irrecovable Descendant's Trust F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC on June 8, 2022.
F2 This transaction was executed in multiple trades at prices ranging from $22.31 to $23.30, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 Held by BioBrit, LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares.
F4 This transaction was executed in multiple trades at prices ranging from $23.33 to $23.80, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5 Held by Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries.
F6 Held by Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries.